Sign in

Schroders plc SDR.L

Price 585p
as of 2026-09-04
60/100
Weak
Quality57
Growth39
Balance-sheet strength46
Valuation82
Momentum70
Income88

Composite 60/100; the shares have moved about 3% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Growth ranks 39/100 — a slight mark against it.

Case for

Income ranks 88/100 — a strong point in its favour. Valuation ranks 82/100 — a strong point in its favour. Momentum ranks 70/100 — a moderate point in its favour.

Case against

Growth ranks 39/100 — a slight mark against it. Balance-sheet strength ranks 46/100 — a slight mark against it.

What the company does Schroders plc is a London-based investment manager offering equity, fixed income, hedge, and alternative funds to institutions, HNWIs, and retail clients. It operates globally with in-house research and advisory services across public and private markets.

Key financials Schroders reports ROE 12%, ROA 2%, and ROCE 5%. Gross, operating, and net margins stand at 78%, 35%, and 16%, respectively. Revenue grew 16% and EPS 85% year-over-year. Debt/equity is 0.13 with a net cash position (-5.8x EBITDA).

Stock health Momentum is strong: +31% over 6m and +51% over 12m, though down 2% from its 52-week high. Sideravia scores Valuation 73 and Momentum 78, while Quality is 56 and Strength 49. Dividend yield is 4% with a 64% payout ratio.

Price vs fair value The stock trades at a PREMIUM of 8.40% to our fair-value estimate (539.36) and a PREMIUM of 7.83% to the 12-month target (542.41). - H1 adjusted operating profit rose 46% (Private Banker International) - Bond market volatility may pressure fixed-income AUM flows (Bloomberg) - Fed policy uncertainty could shift investor allocations away from Treasuries (Bloomberg) - Mixed US equity backdrop may temper near-term sentiment (Reuters)

Looking forward Forward P/E is 16.4x with a PEG of 2.8, suggesting valuation is fair but not cheap. Analysts cite strong H1 results but flag macro headwinds. Momentum remains supportive, though valuation gaps persist.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.